Right ventricular overload and cardiovascular neuroendocrine derangement in systemic sclerosis

European Heart Journal, Supplement

Volumn 6, Issue 6, 2004, Pages

  Emdin, Michele ^a   Marini, Carlo ^a,b   Passino, Claudio ^a   Giuggioli, Dilia ^b   Formichi, Bruno ^a   Ferri, Clodoveo ^c   Khabirinejad, Jaleh ^a   Poletti, Roberta ^a   Prontera, Concetta ^a   Iervasi, Annalisa ^a   L'Abbate, Antonio ^d  

^a INSTITUTE OF CLINICAL PHYSIOLOGY   (Italy)

^b UNIVERSITY OF PISA   (Italy)

^c UNIVERSITY OF MODENA AND REGGIO EMILIA   (Italy)

^d SCUOLA SUPERIORE SANT ANNA   (Italy)

Author keywords

Cardiac natriuretic hormones; Noradrenaline; Pulmonary hypertension; Renin angiotensin aldosterone system; Right ventricular failure; Systemic sclerosis

Indexed keywords

ADRENALIN; ALDOSTERONE; ATRIAL NATRIURETIC FACTOR; BRAIN NATRIURETIC PEPTIDE; CATECHOLAMINE; NEUROHORMONE; NORADRENALIN; RENIN;

ADRENALIN BLOOD LEVEL; ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DOPPLER ECHOGRAPHY; FEMALE; HEART CATHETERIZATION; HEART RIGHT VENTRICLE FAILURE; HEART RIGHT VENTRICLE OVERLOAD; HORMONE DETERMINATION; HORMONE RELEASE; HUMAN; LUNG PRESSURE; MALE; NEUROENDOCRINE SYSTEM; NORADRENALIN BLOOD LEVEL; PLASMA RENIN ACTIVITY; PRIORITY JOURNAL; SYSTEMIC SCLEROSIS; SYSTOLIC BLOOD PRESSURE; VASOCONSTRICTION; VASODILATATION;

EID: 8644258564     PISSN: 1520765X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ehjsup.2004.09.010     Document Type: Article

References (30)

1. T.A. Medsger Jr Systemic sclerosis (scleroderma): clinical aspects W.J. Koopman Arthritis and allied conditions. A textbook of rheumatology vol. II 1997 Williams & Wilkins Philadelphia 1433 1465
2. A. Deswal, and W.P. Follansbee Cardiac involvement in scleroderma Rheum Dis Clin North America 22 1996 841 861
3. J.G. Coghlan, and D. Mukerjee The heart and pulmonary vasculature in scleroderma: clinical features and pathobiology Curr Opin Rheumatol 13 2001 495 499
4. G. Valentini, D.F. Vitale, and A. Giunta Diastolic abnormalities in systemic sclerosis: evidence for associated defective cardiac functional reserve Ann Rheum Dis 55 1996 455 460
5. R.J. Siegel, B. O'Connor, and I. Mena Left ventricular function at rest and during Raynaud's phenomenon in patients with scleroderma Am Heart J 108 1984 1469 1476
6. C. Ferri, L. Bernini, and M.G. Bongiorni Noninvasive evaluation of cardiac dysrhythmias, and their relationship with multisystemic symptoms, in progressive systemic sclerosis patients Arthritis Rheum 28 1985 1259 1266
7. N.K. Roberts, W.R. Cabeen, and J. Moss The prevalence of conduction defects and cardiac arrhythmias in progressive systemic sclerosis Ann Int Med 94 1981 38 40
8. C. Ferri, M. Emdin, and D. Giuggioli Autonomic dysfunction in systemic sclerosis: time and frequency domain 24-hour heart rate variability analysis Br J Rheumatol 36 1997 669 676
9. A.J. MacGregor, R. Canavan, and C. Knight Pulmonary hypertension in systemic sclerosis: risk factors for progression and consequences for survival Rheumatology 40 2001 453 459
10. C. Ferri, G. Valentini, and F. Cozzi Systemic sclerosis: demographic, clinical, and serologic features and survival in 1,012 Italian patients Medicine (Baltimore) 8 2002 139 153
11. M. Packer How should physicians view heart failure? The philosophical and physiological evolution of three conceptual models of the disease Am J Cardiol 25 71 1993 3 11
12. M. Packer Evolution of the neurohormonal hypothesis to explain the progression of chronic heart failure Eur Heart J Suppl. F 1995 4 6
13. J.N. Cohn, T.B. Levine, and M.T. Olivari Plasma norepinephrine as a guide to prognosis in patients with chronic congestive heart failure N Engl J Med 311 1984 819 823
14. CONSENSUS Trial Study Group K. Swedberg, P. Eneroth, J. Kjekshus, and L. Wilhelmsen Hormones regulating cardiovascular function in patients with severe congestive heart failure and their relation to mortality Circulation 82 1990 1730 1736
15. A. Clerico, G. Iervasi, and M.G. Del Chicca Circulating levels of cardiac natriuretic peptides (ANP and BNP) measured by highly sensitive and specific immunoradiometric assays in normal subjects and in patients with different degrees of heart failure J Endocrinol Invest 21 1998 170 179
16. W.J. Remme, and K. Swedberg Guidelines for the diagnosis and treatment of chronic heart failure Eur Heart J 22 2001 1527 1560
17. M.A. Hamilton, L.W. Stevenson, M. Luu, and J.A. Walden Altered thyroid hormone metabolism in advanced heart failure J Am Coll Cardiol 16 1990 91 95
18. G. Iervasi, A. Pingitore, and P. Landi Low-T3 syndrome: a strong prognostic predictor of death in patients with heart disease Circulation 107 2003 708 713
19. A.T. Masi, G.P. Rodnan, and T.A. Medsger Jr Preliminary criteria for the classification of systemic sclerosis (scleroderma) Arthritis Rheum 23 1980 581 590
20. A.T. Masi Classification of systemic sclerosis (scleroderma): relationship of cutaneous subgroups in early disease to outcome and serological reactivity J Rheumatol 15 1988 894 898
21. C. Ferri, L. Bernini, and R. Cecchetti Cutaneous and serological subsets of systemic sclerosis J Rheumatol 18 1991 1826 1832
22. H.R. Maricq Widefield capillary microscopy: technique and rating scale for abnormalities seen in scleroderma and related disorders Arthritis Rheum 24 1981 1159 1165
23. E. Kazzam, K. Caidahl, and T. Hedner Plasma noradrenaline and neuropeptide-Y may not be of primary importance in the pathophysiology of cardiac involvement in systemic sclerosis Scand J Rheumatol 28 1999 238 243
24. E. Kazzam, K. Caidahl, and T. Hedner Atrial natriuretic peptide: relation to left ventricular filling properties inpatients with systemic sclerosis Int J Cardiol 47 1994 151 156
25. C. Passino, A.M. Sironi, B. Favilli et al. Right heart overload contributes to cardiac natriuretic hormone elevation in patients with heart failure. Int J Cardiol, 2004, in press
26. N. Nagaya, T. Nishikimi, and Y. Okano Plasma brain natriuretic peptide levels increase in proportion to the extent of right ventricular dysfunction in pulmonary hypertension J Am Coll Cardiol 31 1998 202 208
27. I.I. Tulevski, M. Grenink, and E.E. van der Wall Increased brain and atrial natriuretic peptides in patients with chronic right ventricular pressure overload: correlation between plasma neurohormones and right ventricular dysfunction Heart 86 2001 27 30
28. K.L. Baughman B-type natriuretic peptide - a window to the heart N Engl J Med 18 347 2002 158 159
29. B.A. Groenning, J.C. Nilsson, and L. Sondergaard Evaluation of impaired left ventricular ejection fraction and increased dimensions by multiple neurohormonal plasma concentrations Eur J Heart Fail 3 2001 699 708
30. J. Koglim, S. Pehlivanli, and M. Schwaiblmair Role of brain natriuretic peptide in risk stratification of patients with congestive heart failure J Am Coll Cardiol 38 2001 1934 1941